Search Results - "Tatineni, V."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Outcomes of Immunotherapy (ICI) Alone vs. Stereotactic Radiosurgery (SRS) Alone vs. ICI and SRS Combined in Melanoma Brain Metastasis by O'Shea, P.J., Tatineni, V., Rauf, Y., Jia, X., Murphy, E.S., Chao, S.T., Suh, J.H., Peereboom, D., Ahluwalia, M.

    “…Melanoma is the third most common cause of metastatic brain tumors. Both Immune Checkpoint Inhibitors (ICIs) and Stereotactic Radiosurgery (SRS) have been used…”
    Get full text
    Journal Article
  3. 3

    Outcomes of BRAF Mutated vs. Wild Type Tumors in Melanoma Brain Metastasis by O'Shea, P.J., Tatineni, V., Rauf, Y., Jia, X., Murphy, E.S., Chao, S.T., Suh, J.H., Peereboom, D., Ahluwalia, M.

    “…Melanoma is the third most common cause of metastatic brain tumors. A mutation of the BRAF protein, a kinase implicated in cell differentiation and growth, is…”
    Get full text
    Journal Article
  4. 4

    Outcomes of BRAF, MET, RET, and ROS1 Mutated Non-Small Cell Lung Cancer With Brain Metastases (NSCLCBM) by Tatineni, V., O'Shea, P.J., Rauf, Y., Jia, X., Murphy, E.S., Chao, S.T., Suh, J.H., Peereboom, D., Ahluwalia, M.

    “…Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) also accounts for the highest number of brain…”
    Get full text
    Journal Article
  5. 5

    Outcomes of Immune-Checkpoint Inhibitors (ICIs) and Stereotactic Radiosurgery (SRS) in Non-Small Cell Lung Cancer Brain Metastases (NSCLCBM) Patients by Tatineni, V., O'Shea, P.J., Rauf, Y., Jia, X., Murphy, E.S., Chao, S.T., Suh, J.H., Peereboom, D., Ahluwalia, M.

    “…Non-small cell lung cancer (NSCLC) is the leading cause of brain metastases. Systemic therapies and radiation therapy are both potential treatment options for…”
    Get full text
    Journal Article
  6. 6

    Outcomes of Immunotherapy (ICI) Alone vs. Stereotactic Radiosurgery (SRS) Alone vs. ICI and SRS Combined in Renal Cell Carcinoma Brain Metastasis by O'Shea, P.J., Tatineni, V., Rauf, Y., Jia, X., Murphy, E.S., Chao, S.T., Suh, J.H., Peereboom, D., Ahluwalia, M.

    “…Renal cell carcinoma is the fourth most common cause of metastatic brain tumors. Both Immune Checkpoint Inhibitors (ICIs) and Stereotactic Radiosurgery (SRS)…”
    Get full text
    Journal Article
  7. 7

    Optimal management of atypical hemolytic uremic disease: challenges and solutions by Raina, Rupesh, Grewal, Manpreet K, Radhakrishnan, Yeshwanter, Tatineni, Vineeth, DeCoy, Meredith, Burke, Linda Lg, Bagga, Arvind

    “…Atypical hemolytic uremic syndrome (aHUS) is a chronic life threatening condition that arises from genetic abnormalities resulting in uncontrolled complement…”
    Get full text
    Journal Article